CHUNG, K. F. (2017). Mitochondrial Dysfunction as a Therapeutic Target in COPD. (e242177). TANAFFOS (Respiration), 16(1(supplement)), e242177

CHUNG, K. F. "Mitochondrial Dysfunction as a Therapeutic Target in COPD" .e242177 , TANAFFOS (Respiration), 16, 1(supplement), 2017, e242177.

CHUNG K. F. (2017). 'Mitochondrial Dysfunction as a Therapeutic Target in COPD', TANAFFOS (Respiration), 16(1(supplement)), e242177.

K. F. CHUNG, "Mitochondrial Dysfunction as a Therapeutic Target in COPD," TANAFFOS (Respiration), 16 1(supplement) (2017): e242177,

CHUNG K. F. Mitochondrial Dysfunction as a Therapeutic Target in COPD. TANAFFOS (Respiration). 2017;16(1(supplement)):e242177.